Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
BUG-ID is a Marie Sklodowska-Curie Doctoral Network project, funded by the European Commission, Horizon Europe Program. Commencing its activities in January 2026, the Network will provide PhD
-
at its facilities in Bellaterra (Barcelona), Spain as part of the AuSpire researcher training program, co-funded by the European Commission under the MSCA COFUND scheme. The total working hours per week
-
Health. METAMIC 3 is funded by the European Commission under the Horizon Europe framework programme (Grant Agreement number 101225682). The METAMIC 3 project will embed Doctoral Candidates (DCs) in a
-
of around £15 million, derived from many sources including the Research Councils (EPSRC, BBSRC, MRC, and NERC), European Commission and a wide range of charities and industrial partners in the UK, Europe and
-
Entity. Additional comments The remuneration, in line with the European Commission rules for Marie Skłodowska-Curie grant holders, will consist of a gross annual salary of 37,000 EUR. The definite amount
-
University Hospital Munich, Germany. The position is funded by the European Commission through the MSCA Doctoral Network Endotrain (Grant No: 101227148) and coordinated by the University of Bergen, Norway
-
? No Offer Description INTEGRATE is an international, multidisciplinary Marie Sklodowska-Curie Doctoral Network funded by the European Commission under Horizon Europe (Grant agreement ID: 101226862
-
and human interactions". BLUEGREEN GOVERNANCE project has been funded by Europe Programme, through the Grant Agreement number 101086091, signed by the European Commission on 16/11/2023 and in which
-
of their health data used for research and treatment purposes at the Faculty of Law, University of Bergen, Norway. The position is funded by the European Commission through the MSCA Doctoral Network Endotrain
-
newly funded European Commission grant entitled ‘Advancing Clinical Care and Equity Through Scalable Solutions In Alzheimer’s Disease Diagnosis and Treatment’ (ACCESS-AD). Responsibilities will include